Back
Regions Financial Vs. Axsome Therapeutics Industry Stock Comparison
Buy
63
RF
Regions Financial
Last Price:
$21.58
Seasonality Move:
0.72%
Sell
35
AXSM
Axsome Therapeutics
Last Price:
$111.64
Seasonality Move:
19.74%
Buy
63
Regions Financial (RF)
is a Buy
Is Regions Financial a Buy, Sell or Hold?
-
The current Regions Financial [RF] share price is $21.73. The Score for RF is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
RF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Axsome Therapeutics (AXSM)
is a Sell
Is Axsome Therapeutics a Buy, Sell or Hold?
-
The current Axsome Therapeutics [AXSM] share price is $111.67. The Score for AXSM is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
AXSM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RF Stock Price Chart
What is Regions Financial's stock price today?
-
The Regions Financial share price today is $21.73Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RF is experiencing slight buying pressure.
AXSM Stock Price Chart
What is Axsome Therapeutics's stock price today?
-
The Axsome Therapeutics share price today is $111.67Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AXSM is experiencing slight buying pressure.
RF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 42.76 | Sell |
Chaikin Money Flow: | 5998009 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AXSM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 36.05 | Sell |
Chaikin Money Flow: | 647254 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.19 - 127.47) | Sell |
Bollinger Bands (100): | (89.52 - 121.2) | Buy |
RF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.93 | Sell |
20-day SMA: | 21.81 | Sell |
50-day SMA: | 23.28 | Sell |
200-day SMA: | 22.96 | Sell |
8-day EMA: | 21.83 | Sell |
20-day EMA: | 22.09 | Sell |
50-day EMA: | 22.88 | Sell |
200-day EMA: | 22.76 | Sell |
AXSM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 120.51 | Sell |
20-day SMA: | 122.32 | Sell |
50-day SMA: | 118.5 | Sell |
200-day SMA: | 95.68 | Buy |
8-day EMA: | 118.83 | Sell |
20-day EMA: | 121.23 | Sell |
50-day EMA: | 116.96 | Sell |
200-day EMA: | 99.27 | Buy |
Regions Financial Earnings Growth & RF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.15 per share, and an increase next year of $0.23 per share.
Axsome Therapeutics Earnings Growth & AXSM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $1.82 per share, and an increase next year of $4.87 per share.
Regions Financial Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Axsome Therapeutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |